325. Hereditary autoinflammatory syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 5 / Drugs : 11 - (DrugBank : 6) / Drug target genes : 2 - Drug target pathways : 35
Hereditary autoinflammatory syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
ID | Diseases (Sorted by drug repositionability) |
---|---|
325 | Hereditary autoinflammatory syndrome |
46 | Malignant rheumatoid arthritis |
49 | Systemic lupus erythematosus |
51 | Scleroderma |
65 | Primary immunodeficiency |
84 | Sarcoidosis |
96 | Crohn disease |
256 | Muscle glycogenosis |
53 | Sjogren syndrome |
271 | Ankylosing spondylitis |
162 | Pemphigoid |
228 | Bronchiolitis obliterans |
265 | Lipodystrophy |
93 | Primary biliary cholangitis |
50 | Dermatomyositis |
107 | Juvenile idiopathic arthritis |
97 | Ulcerative colitis |
40 | Takayasu arteritis |
41 | Giant cell arteritis |
269 | Pyogenic arthritis |
11 | Myasthenia gravis |
44 | Wegener granulomatosis |
268 | Nakajo-Nishimura syndrome |